What is the latest news on INBX? | Glauxie AI

Q: What is the latest news on INBX?

24 news articles for INBX in the past 30 days. Latest: "Should Positive INBRX-106 Phase 2 Head and Neck Data Require Action From Inhibrx Biosciences (INBX) Investors?". 2 SEC Form 8-K filings in the past 90 days.

Q: What happened to INBX today?

Get a recap of what happened to INBX stock today — price move, catalysts, and key events.

Q: Why is INBX going up today?

Find out why INBX stock is up today with real-time data, news catalysts, and move analysis.

Q: Why is INBX down today?

Find out why INBX stock is down today with real-time data, news catalysts, and move analysis.

What is the latest news on INBX?

🦉

Latest News & Events — INBX

24 articles in the past 30 days

Merck Broadens KEYTRUDA Collaborations As Patent Expiry Pressure Builds
Yahoo Finance ·

Should Positive INBRX-106 Phase 2 Combo Data in Head and Neck Cancer Require Action From Inhibrx Biosciences (INBX) Investors? - simplywall.st
Google News ·

Inhibrx Biosciences Reports Positive Interim Phase 2 Results - TipRanks
Google News ·

Inhibrx Cancer Treatment Shows High Response Rates In Head And Neck Cancer Study
Benzinga-News ·

Why Is Inhibrx Biosciences Stock Trading Higher Today? - Inhibrx Biosciences (NASDAQ:INBX) - Benzinga
Google News ·

Inhibrx Biosciences’ INBRX-106 Combo Tops KEYTRUDA Alone in Phase 2 Cancer Study
Yahoo Finance ·

This Biotech Stock Surges After Positive Cancer Trial Results. What to Know.
Yahoo Finance ·

Analyst Actions

Firm	Action	Date

SEC Form 8-K Filings (2 in 90 days)

—

INBX News INBX Overview

What happened to INBX today? Why is INBX going up today? Why is INBX down today?

Latest News & Events — INBX

Top Stories

Analyst Actions

SEC Form 8-K Filings (2 in 90 days)

Sign in to InsiderStreet